Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Itopride reduces esophageal acid exposure in GERD

Nov. 7, 2003

Antiestrogen fulvestrant prevents gallstone formation

Nov. 7, 2003

DA-9601 provides high-quality ulcer healing in experimental rat model

Nov. 7, 2003

AZD-3582 associated with better intestinal tolerance compared to naproxen

Nov. 7, 2003

Viramidine heads for late-stage clinical testing

Nov. 7, 2003

Berna grants HBsAg rights to Dynavax

Nov. 6, 2003

Nexium i.v. provides faster and more effective acid control than pantoprazole

Nov. 6, 2003

Chiron grants license to Rigel for hepatitis C technology

Nov. 5, 2003

Benefits described for pirfenidone in the treatment of NASH and liver cirrhosis

Nov. 5, 2003

Combination of UDCA and MMF in the treatment of sclerosing cholangitis

Nov. 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...